Welcome to LookChem.com Sign In|Join Free
  • or
3-Cyclopropylphenol is a chemical compound that belongs to the class of phenols and phenol derivatives. It is an aromatic compound with a hydroxyl group directly attached to an aromatic ring, featuring a cyclopropyl group as a substituent on the phenolic ring. The properties and applications of 3-Cyclopropylphenol, such as its physical characteristics and toxicological profile, are influenced by its purity, specific form, and the context in which it is used.

28857-88-7

Post Buying Request

28857-88-7 Suppliers

Recommended suppliers

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

28857-88-7 Usage

Uses

Used in Chemical Synthesis:
3-Cyclopropylphenol is used as a chemical intermediate in the synthesis of other compounds. It serves as a reactant in various chemical reactions, contributing to the formation of new molecules with potential applications in different industries.
Used in Laboratory Research:
3-Cyclopropylphenol is used as a research compound in laboratories, where it may be employed to study its properties, reactions, and potential applications. It can be a valuable tool for understanding the behavior of phenols and their derivatives in chemical processes.
Used in Industrial Applications:
3-Cyclopropylphenol is used in industrial settings for the production of various products. Its role in these applications may involve serving as a starting material or a catalyst in the manufacturing process, depending on the specific requirements of the industry.
For more detailed information on the properties of 3-Cyclopropylphenol, such as its boiling point, melting point, and solubility, one can refer to its Material Safety Data Sheet (MSDS). This document provides a comprehensive overview of the compound's characteristics and safety considerations, which are essential for its safe handling and use in various applications.

Check Digit Verification of cas no

The CAS Registry Mumber 28857-88-7 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 2,8,8,5 and 7 respectively; the second part has 2 digits, 8 and 8 respectively.
Calculate Digit Verification of CAS Registry Number 28857-88:
(7*2)+(6*8)+(5*8)+(4*5)+(3*7)+(2*8)+(1*8)=167
167 % 10 = 7
So 28857-88-7 is a valid CAS Registry Number.
InChI:InChI=1/C9H10O/c10-9-3-1-2-8(6-9)7-4-5-7/h1-3,6-7,10H,4-5H2

28857-88-7Downstream Products

28857-88-7Relevant academic research and scientific papers

ANTIVIRAL 1,3-DI-OXO-INDENE COMPOUNDS

-

, (2021/10/22)

This disclosure provides compounds of Formula (I) as described herein, along with pharmaceutically acceptable salts, pharmaceutical compositions containing such compounds, and methods to use these compounds, salts and compositions for treating viral infections.

HCV POLYMERASE INHIBITORS

-

Page/Page column 62, (2020/02/14)

The invention provides compounds of the formula:wherein B is a nucleobase selected from the groups (a) to (d):and the other variables are as defined in the claims, which are of use in the treatment or prophylaxis of hepatitis C virus infection, and related aspects.

DIOXOLANE ANALOGUES OF URIDINE FOR THE TREATMENT OF CANCER

-

, (2016/03/22)

The invention provides compounds of formula (I), wherein: R1 is OR11, or NR5R5'; R2 is H or F; R5 is H, C1-C6alkyl, OH, C(=O)R6, O(C=O)R6 or O(C=O)OR6; R5′ is H or C1-C6alkyl; R6 is C1-C6alkyl or C3-C7cycloalkyl; R13 is H, phenyl, pyridyl, benzyl, indolyl or naphthyl wherein the phenyl, pyridyl, benzyl, indolyl and naphthyl is optionally substituted with 1, 2 or 3 R22; and the other variables are as defined in the claims, which are of use in the treatment of cancer, and related aspects.

HCV POLYMERASE INHIBITORS

-

, (2015/03/28)

The invention provides compounds of the formula:(I) wherein B is a nucleobase selected from the groups (a) to (d) and the other variables are as defined in the claims, which are of use in the treatment or prophylaxis of hepatitis C virus infection, and related aspects.

HCV POLYMERASE INHIBITORS

-

, (2015/05/05)

The invention provides compounds of the formula (I) wherein B is a nucleobase selected from the groups (a) to (d): and the other variables are as defined in the claims, which are of use in the treatment or prophylaxis of hepatitis C virus infection, and related aspects.

NOVEL COMPOUNDS, ISOMER THEREOF, OR PHARMACEUTICALLY ACCEPTABLE SALTS THEREOF AS VANILLOID RECEPTOR ANTAGONIST AND PHARMACEUTICAL COMPOSITIONS CONTAINING THE SAME

-

Page/Page column 67-68, (2010/04/03)

This present invention relates to novel compounds, isomer thereof or pharmaceutically acceptable salts thereof as vanilloid receptor (Vanilloid Receptor 1; VR1; TRPV1) antagonist; and a pharmaceutical composition containing the same. The present invention provides a pharmaceutical composition for preventing or treating a disease such as pain, migraine, arthralgia, neuralgia, neuropathies, nerve injury, skin disorder, urinary bladder hypersensitiveness, irritable bowel syndrome, fecal urgency, a respiratory disorder, irritation of skin, eye or mucous membrane, stomach-duodenal ulcer, inflammatory diseases, ear disease, heart disease and so on.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1 Customer Service

What can I do for you?
Get Best Price

Get Best Price for 28857-88-7